The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery Disease

Conclusions
After a median follow-up period of 17 months, PCI with new-generation drug-eluting stents was associated with an overall low rate of the composite endpoint of death, MI, or cerebrovascular accident.

Source: Journal of the American College of Cardiology: Cardiovascular Interventions - December 4, 2017 Category: Cardiology Authors: Chieffo, A., Tanaka, A., Giustino, G., Briede, I., Sawaya, F. J., Daemen, J., Kawamoto, H., Meliga, E., DAscenzo, F., Cerrato, E., Stefanini, G. G., Capodanno, D., Mangiameli, A., Templin, C., Erglis, A., Morice, M. C., Mehran, R., Van Mieghem, N. M., Nak Tags: Coronary: Focus on Stent Technology Source Type: research